drug · small molecule
azeliragon
Phase 3updated 3mo agoby Cantex Pharmaceuticals Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
targets
Advanced glycosylation end product-specific receptor
all catalysts(0)
nothing on the calendar yet
Trials studying azeliragon
- phase2Azeliragon in MGMT Unmethylated Glioblastoma
- phase2Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
- EP1Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
- phase2Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that